Patents by Inventor Fen-Ni Fu

Fen-Ni Fu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NANOCARRIERS POSSESSING COMPONENTS WITH DIFFERENT RATES OF RELEASE
    Publication number: 20200390881
    Abstract: This invention relates to compositions, and related methods, of synthetic nanocarriers that comprise immunomodulatory agents and antigens that are differentially released from the synthetic nanocarriers.
    Type: Application
    Filed: January 27, 2020
    Publication date: December 17, 2020
    Applicant: Selecta Biosciences, Inc.
    Inventors: Grayson B. Lipford, Charles Zepp, Yun Gao, Mark J. Keegan, Sam Baldwin, Fen-ni Fu, Lloyd Johnston
  • Morphinan Derivatives for the Treatment of Drug Overdose
    Publication number: 20200345718
    Abstract: The instant application relates to morphinan derivatives of Formula I with sustained effectiveness in treating drug toxicity and overdose:
    Type: Application
    Filed: February 7, 2020
    Publication date: November 5, 2020
    Inventors: Bernard Silverman, Fen-Ni Fu, Chengyun Guo
  • IMMUNOMODULATORY AGENT-POLYMERIC COMPOUNDS
    Publication number: 20180256709
    Abstract: This invention relates to compositions, and related compounds and methods, of conjugates of immunomodulatory agents and polymers or unit(s) thereof. The conjugates may be contained within synthetic nanocarriers, and the immunomodulatory agents may be released from the synthetic nanocarriers in a pH sensitive manner.
    Type: Application
    Filed: February 5, 2018
    Publication date: September 13, 2018
    Applicant: Selecta Biosciences, Inc.
    Inventors: Charles Zepp, Grayson B. Lipford, Yun Gao, Lloyd Johnston, Fen-ni Fu, Mark J. Keegan, Sam Baldwin
  • Immunomodulatory agent-polymeric compounds
    Patent number: 9884112
    Abstract: This invention relates to compositions, and related compounds and methods, of conjugates of immunomodulatory agents and polymers or unit(s) thereof. The conjugates may be contained within synthetic nanocarriers, and the immunomodulatory agents may be released from the synthetic nanocarriers in a pH sensitive manner.
    Type: Grant
    Filed: March 13, 2015
    Date of Patent: February 6, 2018
    Assignee: Selecta Biosciences, Inc.
    Inventors: Charles Zepp, Grayson B. Lipford, Yun Gao, Lloyd Johnston, Fen-ni Fu, Mark J. Keegan, Sam Baldwin
  • Morphinan Derivatives for the Treatment of Drug Overdose
    Publication number: 20170333422
    Abstract: The instant application relates to morphinan derivatives of Formula I with sustained effectiveness in treating drug toxicity and overdose:
    Type: Application
    Filed: June 5, 2017
    Publication date: November 23, 2017
    Inventors: Bernard Silverman, Fen-Ni Fu, Chengyun Guo
  • Morphinan Derivatives for the Treatment of Drug Overdose
    Publication number: 20160051535
    Abstract: The instant application relates to morphinan derivatives of Formula I with sustained effectiveness in treating drug toxicity and overdose:
    Type: Application
    Filed: August 25, 2015
    Publication date: February 25, 2016
    Inventors: Bernard Silverman, Fen-Ni Fu, Chengyun Guo
  • IMMUNOMODULATORY AGENT-POLYMERIC COMPOUNDS
    Publication number: 20150328300
    Abstract: This invention relates to compositions, and related compounds and methods, of conjugates of immunomodulatory agents and polymers or unit(s) thereof. The conjugates may be contained within synthetic nanocarriers, and the immunomodulatory agents may be released from the synthetic nanocarriers in a pH sensitive manner.
    Type: Application
    Filed: March 13, 2015
    Publication date: November 19, 2015
    Applicant: Selecta Biosciences, Inc.
    Inventors: Charles Zepp, Grayson B. Lipford, Yun Gao, Lloyd Johnston, Fen-ni Fu, Mark J. Keegan, Sam Baldwin
  • Morphinan derivatives for the treatment of drug overdose
    Patent number: 9119848
    Abstract: The instant application relates to morphinan derivatives of Formula I with sustained effectiveness in treating drug toxicity and overdose:
    Type: Grant
    Filed: October 13, 2010
    Date of Patent: September 1, 2015
    Assignee: Alkermes Pharma Ireland Limited
    Inventors: Bernard Silverman, Fen-Ni Fu, Chengyun Guo
  • Immunomodulatory agent-polymeric compounds
    Patent number: 9006254
    Abstract: This invention relates to compositions, and related compounds and methods, of conjugates of immunomodulatory agents and polymers or unit(s) thereof. The conjugates may be contained within synthetic nanocarriers, and the immunomodulatory agents may be released from the synthetic nanocarriers in a pH sensitive manner.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: April 14, 2015
    Assignee: Selecta Biosciences, Inc.
    Inventors: Charles Zepp, Grayson B. Lipford, Yun Gao, Lloyd Johnston, Fen-ni Fu, Mark J. Keegan, Sam Baldwin
  • TARGETED SYNTHETIC NANOCARRIERS WITH PH SENSITIVE RELEASE OF IMMUNOMODULATORY AGENTS
    Publication number: 20140242173
    Abstract: This invention relates to compositions, and related methods, of synthetic nanocarriers that target sites of action in cells, such as antigen presenting cells (APCs), and comprise immunomodulatory agents that dissociate from the synthetic nanocarriers in a pH sensitive manner. Also disclosed are compositions and methods relating to synthetic nanocarriers that encapsulate labile immunomodulatory agents that dissociate from the synthetic nanocarriers in a pH sensitive manner.
    Type: Application
    Filed: May 8, 2014
    Publication date: August 28, 2014
    Applicant: Selecta Biosciences, Inc.
    Inventors: Charles Zepp, Yun Gao, Mark J. Keegan, Sam Baldwin, Fen-ni Fu, Lloyd Johnston, Grayson B. Lipford
  • IMMUNOMODULATORY AGENT-POLYMERIC COMPOUNDS
    Publication number: 20140193453
    Abstract: This invention relates to compositions, and related compounds and methods, of conjugates of immunomodulatory agents and polymers or unit(s) thereof. The conjugates may be contained within synthetic nanocarriers, and the immunomodulatory agents may be released from the synthetic nanocarriers in a pH sensitive manner.
    Type: Application
    Filed: December 23, 2013
    Publication date: July 10, 2014
    Applicant: SELECTA BIOSCIENCES, INC.
    Inventors: CHARLES ZEPP, GRAYSON B. LIPFORD, YUN GAO, LLOYD JOHNSTON, FEN-NI FU, MARK J. KEEGAN, SAM BALDWIN
  • TARGETED SYNTHETIC NANOCARRIERS WITH PH SENSITIVE RELEASE OF IMMUNOSTIMULATORY AGENTS
    Publication number: 20140030344
    Abstract: This invention relates to compositions, and related methods, of synthetic nanocarriers that target sites of action in cells, such as antigen presenting cells (APCs), and comprise immunomodulatory agents that dissociate from the synthetic nanocarriers in a pH sensitive manner. Also disclosed are compositions and methods relating to synthetic nanocarriers that encapsulate labile immunomodulatory agents that dissociate from the synthetic nanocarriers in a pH sensitive manner.
    Type: Application
    Filed: July 22, 2013
    Publication date: January 30, 2014
    Applicant: Selecta Biosciences, Inc.
    Inventors: Charles Zepp, Yun Gao, Mark J. Keegan, Sam Baldwin, Fen-ni Fu, Lloyd Johnston, Grayson B. Lipford
  • Immunomodulatory agent-polymeric compounds
    Patent number: 8629151
    Abstract: This invention relates to compositions, and related compounds and methods, of conjugates of immunomodulatory agents and polymers or unit(s) thereof. The conjugates may be contained within synthetic nanocarriers, and the immunomodulatory agents may be released from the synthetic nanocarriers in a pH sensitive manner.
    Type: Grant
    Filed: May 26, 2010
    Date of Patent: January 14, 2014
    Assignee: Selecta Biosciences, Inc.
    Inventors: Charles Zepp, Grayson B. Lipford, Yun Gao, Lloyd Johnston, Fen-ni Fu, Mark J. Keegan, Sam Baldwin
  • SYNTHETIC NANOCARRIER VACCINES COMPRISING PEPTIDES OBTAINED OR DERIVED FROM HUMAN INFLUENZA A VIRUS HEMAGGLUTININ
    Publication number: 20120064110
    Abstract: This invention relates to compositions and methods that can be used immunize a subject against influenza. Generally, the compositions and methods include peptides obtained or derived from human influenza A virus hemagglutinin.
    Type: Application
    Filed: August 19, 2011
    Publication date: March 15, 2012
    Applicant: Selecta Biosciences, Inc.
    Inventors: Petr Ilyinskii, Yun Gao, Fen-ni Fu, Grayson B. Lipford
  • IMMUNOMODULATORY AGENT-POLYMERIC COMPOUNDS
    Publication number: 20110027217
    Abstract: This invention relates to compositions, and related compounds and methods, of conjugates of immunomodulatory agents and polymers or unit(s) thereof. The conjugates may be contained within synthetic nanocarriers, and the immunomodulatory agents may be released from the synthetic nanocarriers in a pH sensitive manner.
    Type: Application
    Filed: May 26, 2010
    Publication date: February 3, 2011
    Applicant: SELECTA BIOSCIENCES, INC.
    Inventors: CHARLES ZEPP, GRAYSON B. LIPFORD, YUN GAO, LLOYD JOHNSTON, FEN-NI FU FU, MARK J. KEEGAN, SAM BALDWIN
  • TARGETED SYNTHETIC NANOCARRIERS WITH PH SENSITIVE RELEASE OF IMMUNOMODULATORY AGENTS
    Publication number: 20110020388
    Abstract: This invention relates to compositions, and related methods, of synthetic nanocarriers that target sites of action in cells, such as antigen presenting cells (APCs), and comprise immunomodulatory agents that dissociate from the synthetic nanocarriers in a pH sensitive manner. Also disclosed are compositions and methods relating to synthetic nanocarriers that encapsulate labile immunomodulatory agents that dissociate from the synthetic nanocarriers in a pH sensitive manner.
    Type: Application
    Filed: May 26, 2010
    Publication date: January 27, 2011
    Applicant: Selecta Biosciences, Inc.
    Inventors: CHARLES ZEPP, Yun Gao, Mark J. Keegan, Sam Baldwin, Fen-ni Fu, Lloyd Johnston, Grayson B. Lipford
  • NANOCARRIERS POSSESSING COMPONENTS WITH DIFFERENT RATES OF RELEASE
    Publication number: 20100303850
    Abstract: This invention relates to compositions, and related methods, of synthetic nanocarriers that comprise immunomodulatory agents and antigens that are differentially released from the synthetic nanocarriers.
    Type: Application
    Filed: May 26, 2010
    Publication date: December 2, 2010
    Applicant: Selecta Biosciences, Inc.
    Inventors: Grayson B. Lipford, Charles Zepp, Yun Gao, Mark J. Keegan, Sam Baldwin, Fen-ni Fu, Llyod Johnston
  • High load particles for inhalation having rapid release properties
    Publication number: 20070123449
    Abstract: The invention generally relates to formulations having particles comprising phospholipids, bioactive agent and excipients and the pulmonary delivery thereof. Dry powder inhaled insulin formulations are disclosed. Improved formulations comprising DPPC, insulin and sodium citrate which are useful in the treatment of diabetes are disclosed. Also, the invention relates to a method of for the pulmonary delivery of a bioactive agent comprising administering to the respiratory tract of a patient in need of treatment, or diagnosis an effective amount of particles comprising a bioactive agent or any combination thereof in association, wherein release of the agent from the administered particles occurs in a rapid fashion.
    Type: Application
    Filed: October 31, 2006
    Publication date: May 31, 2007
    Applicant: Advanced Inhalation Research, Inc.
    Inventors: Henry Brush, Fen-Ni Fu, Michael Lipp, Jennifer Schmitke